Bumper Offer - Urjas oil Just @ Rs. 1
After is an allopathic medicine The correct dosage of After depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
After is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when After is used -
Severe
Moderate
Mild
Common
Is the use of After safe for pregnant women?
Pregnant women can take After without worrying about any side effects.
Is the use of After safe during breastfeeding?
Taking After may lead to serious side effects if you are breastfeeding. After should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of After on the Kidneys?
There can be some harmful effects on your kidneys after taking After. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of After on the Liver?
The liver can be affected by After. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart After only after medical advice.
What is the effect of After on the Heart?
Using After does not have any harmful effects on the heart.
After should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take After unless your doctor advises you to do so -
Is this After habit forming or addictive?
No, you will not get addicted to After.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the After can make you feel drowsy.
Is it safe?
Yes, but consume After only on doctor's advice.
Is it able to treat mental disorders?
No, After cannot treat any kind of mental disorder.
Interaction between Food and After
Taking After with food does not harm your health.
Interaction between Alcohol and After
Due to lack of research, there is no information about the side effects of taking After with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177